详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Animal models for SARS-CoV-2 infection and pathology.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics,West China Hospital, Sichuan University, Chengdu, Sichuan, China [2]National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China

出处：

DOI：

关键词： animal models COVID-19 immunology pathology SARS-CoV-2 transmission

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiology of coronavirus disease 2019 (COVID-19) pandemic. Current variants including Alpha, Beta, Gamma, Delta, and Lambda increase the capacity of infection and transmission of SARS-CoV-2, which might disable the in-used therapies and vaccines. The COVID-19 has now put an enormous strain on health care system all over the world. Therefore, the development of animal models that can capture characteristics and immune responses observed in COVID-19 patients is urgently needed. Appropriate models could accelerate the testing of therapeutic drugs and vaccines against SARS-CoV-2. In this review, we aim to summarize the current animal models for SARS-CoV-2 infection, including mice, hamsters, nonhuman primates, and ferrets, and discuss the details of transmission, pathology, and immunology induced by SARS-CoV-2 in these animal models. We hope this could throw light to the increased usefulness in fundamental studies of COVID-19 and the preclinical analysis of vaccines and therapeutic agents.© 2021 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

无

最新[2023]版：

大类 | 3 区医学

小类 | 3 区医学：研究与实验

第一作者：

第一作者机构： [1]Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics,West China Hospital, Sichuan University, Chengdu, Sichuan, China

通讯作者：

通讯机构： [2]National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China [*1]NationalKunmingHigh-levelBiosafety PrimateResearchCenter, Institute ofMedical Biology, ChineseAcademy of Medical Sciences and Peking UnionMedical College, Yunnan, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]环境卫生与监测：新常态下防控COVID-19的双轮效应思考 [2]Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. [3]Re-evaluation of mouse models of endometriosis for pathological and immunological research [4]An integrative analysis identifying transcriptional features and key genes involved in COVID-19. [5]A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles. [6]Discovery and Nanosized Preparations of (S,R)-Tylophorine Malate as Novel anti-SARS-CoV-2 Agents. [7]Can We Use mTOR Inhibitors for COVID-19 Therapy? [8]Fast construction of SARS-CoV-2 associated plasmid library using parallel cloning method [9]Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era [10]SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights